Search - tctmd.com

Displaying 81 - 100 of 185

Sort: Relevancy | Date

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Conference News AHA 2020

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Shelley Wood

November 10, 2020

News Conference News TCT 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Michael O'Riordan

October 19, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Conference News ESC 2020

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

Yael L. Maxwell

September 02, 2020

News Conference News ESC 2020

More Than Half of Patients See a GP in the 2 Weeks Before OHCA

Yael L. Maxwell

August 28, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Daily News

Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population

Todd Neale

September 18, 2019

News Conference News ESC 2019

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Yael L. Maxwell

September 10, 2019

News Conference News ESC 2019

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Todd Neale

September 09, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Yael L. Maxwell

September 04, 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Published Cohort

News Conference News ESC 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Yael L. Maxwell

September 03, 2019

Advertisement

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

AHA Calls Out Structural Racism as Driver of CVD Inequalities

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Just One-Third of European Patients Get to LDL Cholesterol Goals

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

EVAPORATE: Icosapent Ethyl May Slow Atherosclerosis Progression

More Than Half of Patients See a GP in the 2 Weeks Before OHCA

TCTMD’s Top 10 Most Popular Stories for August 2020

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Cardiology After COVID-19: Physicians Predict Lasting Change

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content